BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//UC Berkeley Haas - ECPv6.15.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:UC Berkeley Haas
X-ORIGINAL-URL:https://haas.berkeley.edu
X-WR-CALDESC:Events for UC Berkeley Haas
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20211026T110000
DTEND;TZID=America/Los_Angeles:20211026T120000
DTSTAMP:20260314T170340
CREATED:20211021T022303Z
LAST-MODIFIED:20211026T183803Z
UID:706923-1635246000-1635249600@haas.berkeley.edu
SUMMARY:College of Chemistry: New Developments in Cancer Therapy
DESCRIPTION:On October 26 at 11am PT\, College of Chemistry faculty and alumni will discuss the latest developments in cancer therapies.  \nHear from research and industry professionals at UC Berkeley\, Amgen\, and Eikon Therapeutics as they highlight the recent break-throughs in cancer therapies and outcomes for patients\, including unpacking targeted immunotherapy\, KRAS mutations\, undruggable proteins\, and addressing COVID-19. \nDon’t miss the chance to attend this live lecture and ask your questions of these innovators in the field. \nRegister Here 
URL:https://haas.berkeley.edu/event/college-of-chemistry-new-developments-in-cancer-therapy/
LOCATION:Virtual | Bay Area
CATEGORIES:DAR
END:VEVENT
END:VCALENDAR